Thank you, Madam Chair.
I would like to welcome all the witnesses and apologize for the delay. There have been votes in the House, which delayed the meeting.
Ms. Lévesque, have you conducted any studies and do you have any figures to present? How has the direct impact of ArriveCAN on the entry and transmission of the virus in Canada been analyzed?